W.r.t India, it has mostly accepted the patent obligations of US Pharma as it gets to export generic medications to US and I think 50% of Indian generic medications get through FDA approval.

But this was pre-COVID, not sure how new found gold rush in Pharma industry worldwide would affect the future of Generic medications and patentability of pharma products. It could go either way of improving manufacturing and availability of generic medications (or) Pharma behemoths could take advantage of current situation and derail generic medicine development indefinitely.